This session at Cell & Gene Therapy World Conference 2026 will highlight advances in ex vivo gene editing, focusing on techniques like CRISPR-Cas9 and their applications in treating genetic disorders and cancers. Key discussions will address challenges in precision, scalability, and accessibility, aiming to advance safe and equitable therapies for patients globally.
Industry pioneers and scientists are expected to collaborate at the upcoming Biotechnology Conference USA.